Neurogene expands Rett syndrome trial, doses third patient By Investing.com
[ad_1] © Reuters. NEW YORK – Neurogene Inc. (NASDAQ: NGNE), a biotechnology firm focused on developing genetic therapies for rare neurological diseases, announced today that...
Anixa begins treatment of fourth patient in phase 1 ovarian cancer tiral By Investing.com
[ad_1] © Reuters. SAN JOSE, Calif. – Anixa Biosciences, Inc. (NASDAQ: NASDAQ:), a biotech company specializing in cancer treatment, has started treating the fourth patient...
AI in healthcare: New tech in diagnosis and patient care By Cointelegraph
[ad_1] Artificial intelligence (AI) is no longer a concept confined to science fiction; instead, it has become a part of our everyday lives, driving advancements...
Here is how studying tokens’ price history helps patient traders enjoy consistent average gains. By Cointelegraph
[ad_1] Whether you consider cryptocurrency trading as art, science or a game of skill, one thing is beyond dispute: Those who excel at it are...
Alzheimer’s patient groups pressure U.S. to pay for Biogen drug By Reuters
[ad_1] © Reuters. An advertisement aimed at loosening proposed restrictions on new Alzheimer’s treatments is seen in this undated handout image. UsAgainstAlzheimer?s Action/Handout via REUTERS...